Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction

[1]  D. Grobbee,et al.  Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. , 2003, European heart journal.

[2]  L. Stevenson.  Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant. , 2006, Circulation.

[3]  M. Fiksen-Olsen,et al.  Renal effects of prostaglandin inhibition during increases in renal venous pressure. , 1991, The American journal of physiology.

[4]  R. Carpenter,et al.  Venous excess: a new approach to cardiovascular control and its teaching. , 2005, Journal of applied physiology.

[5]  Lie Gao,et al.  Failure : Roles of Angiotensin II Type 1 Receptors and NAD ( P ) H Oxidase Simvastatin Therapy Normalizes Sympathetic Neural Control in Experimental Heart , 2005 .

[6]  Hans L. Hillege,et al.  Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure , 2006, Circulation.

[7]  L. Stevenson,et al.  The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. , 1989, JAMA.

[8]  J. Halperin,et al.  Acute Regional Circulatory and Renal Hemodynamic Effects of Converting‐enzyme Inhibition in Patients with Congestive Heart Failure , 1981, Circulation.

[9]  M. Guglin,et al.  Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. , 2007, Journal of the American College of Cardiology.

[10]  G. Dibona.  Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. , 2000, Hypertension.

[11]  Lemuel A Moyé,et al.  Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction. , 2002, Journal of the American College of Cardiology.

[12]  H Ector,et al.  Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. , 2001, The New England journal of medicine.

[13]  J. C. Romero,et al.  Renal effects of angiotensin II inhibition during increases in renal venous pressure. , 1992, Hypertension.

[14]  L. Stevenson,et al.  Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. , 2003, Journal of the American College of Cardiology.

[15]  Ali Ahmed,et al.  Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. , 2007, The American journal of cardiology.

[16]  L. Tavazzi,et al.  Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. , 2001, Journal of the American College of Cardiology.

[17]  W. Rand,et al.  Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. , 2001, Journal of the American College of Cardiology.

[18]  J. Hall,et al.  Renal hemodynamic responses to increased renal venous pressure: role of angiotensin II. , 1982, The American journal of physiology.

[19]  S. Favilla,et al.  Vascular Renin‐Angiotensin System and Neurotransmission in Hypertensive Persons , 1991, Hypertension.

[20]  H. De León,et al.  Regulation of glomerular atrial natriuretic factor receptor subtypes by renal sympathetic nerves. , 1991, The American journal of physiology.

[21]  B. J. Tucker,et al.  Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat. , 1976, The Journal of clinical investigation.

[22]  J. Ouyang,et al.  Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure. , 2006, American journal of physiology. Renal physiology.

[23]  M. Redfield,et al.  Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure. , 2005, Kidney international.

[24]  William T. Abraham,et al.  Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness , 2005 .

[25]  L. Stevenson.  Hemodynamic Goals Are Relevant , 2006 .

[26]  V. Kon,et al.  Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive heart failure and acute extracellular fluid volume depletion. , 1985, The Journal of clinical investigation.

[27]  D. Rockey,et al.  Ischemic hepatitis: clinical presentation and pathogenesis. , 2000, The American journal of medicine.

[28]  M. Maxwell,et al.  RENAL VENOUS PRESSURE IN CHRONIC CONGESTIVE HEART FAILURE. , 1950, The Journal of clinical investigation.

[29]  G. Mayer,et al.  Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure. , 1998, Wiener klinische Wochenschrift.

[30]  G. Brandenberger,et al.  Mechanisms of renal hyporesponsiveness to ANP in heart failure , 2003, European journal of clinical investigation.

[31]  M. Domanski,et al.  The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. , 2000, Journal of the American College of Cardiology.

[32]  A. Boyle,et al.  Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. , 2005, Journal of the American College of Cardiology.

[33]  G. Navis,et al.  Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. , 2004, American heart journal.

[34]  R. Blantz,et al.  Changes in glomerular hemodynamic response to angiotensin II after subacute renal denervation in rats. , 1986, The Journal of clinical investigation.

[35]  P. Morsing,et al.  Renal interstitial pressure and tubuloglomerular feedback control in rats during infusion of atrial natriuretic peptide (ANP). , 1992, Acta physiologica Scandinavica.

[36]  B. Brenner,et al.  Role of the kidney in congestive heart failure. , 2009, Acta medica Scandinavica. Supplementum.

[37]  L. Stevenson,et al.  Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. , 1999, American heart journal.

[38]  Monica R. Shah,et al.  Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness The ESCAPE Trial , 2005 .

[39]  P. Seferovic,et al.  Haemodynamic and clinical effects of ularitide in decompensated heart failure. , 2006, European heart journal.

[40]  L. Stevenson.  Design of therapy for advanced heart failure , 2005, European journal of heart failure.

[41]  C. Leier,et al.  Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. , 1984, Circulation.